Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims

被引:273
作者
Pandey, Ghanshyam N. [1 ]
Rizavi, Hooriyah S. [1 ]
Ren, Xinguo [1 ]
Fareed, Jawed [2 ]
Hoppensteadt, Debra A. [2 ]
Roberts, Rosalinda C. [3 ]
Conley, Robert R. [4 ]
Dwivedi, Yogesh [1 ]
机构
[1] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA
[2] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
关键词
Cytokines; Teenage suicide; Postmortem brain; TNF-alpha; IL-1; beta; IL-6; TUMOR-NECROSIS-FACTOR; INTERFERON-ALPHA; DEPRESSIVE SYMPTOMS; MAJOR DEPRESSION; TNF-ALPHA; INTERLEUKIN-6; STRESS; RECEPTOR; EXPRESSION; SCHIZOPHRENIA;
D O I
10.1016/j.jpsychires.2011.08.006
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Teenage suicide is a major public health concern, but its neurobiology is not well understood. Proinflammatory cytokines play an important role in stress and in the pathophysiology of depression-two major risk factors for suicide. Cytokines are increased in the serum of patients with depression and suicidal behavior; however, it is not clear if similar abnormality in cytokines occurs in brains of suicide victims. We therefore measured the gene and protein expression levels of proinflammatory cytokines interleukin (IL)-1 beta, IL-6, and tissue necrosis factor (TNF)-alpha in the prefrontal cortex (PFC) of 24 teenage suicide victims and 24 matched normal control subjects. Our results show that the mRNA and protein expression levels of IL-1 beta, IL-6, and TNF-alpha were significantly increased in Brodmann area 10 (BA-10) of suicide victims compared with normal control subjects. These results suggest an important role for IL-1 beta, IL-6, and TNF-alpha in the pathophysiology of suicidal behavior and that proinflammatory cytokines may be an appropriate target for developing therapeutic agents. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:57 / 63
页数:7
相关论文
共 54 条
[41]   ENDOTOXIN AND INTERLEUKIN-1 DECREASE THE AFFINITY OF HIPPOCAMPAL MINERALOCORTICOID (TYPE-I) RECEPTOR IN PARALLEL TO ACTIVATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS [J].
SCHOBITZ, B ;
SUTANTO, W ;
CAREY, MP ;
HOLSBOER, F ;
DEKLOET, ER .
NEUROENDOCRINOLOGY, 1994, 60 (02) :124-133
[42]   GENE-EXPRESSION AND FUNCTION OF INTERLEUKIN-1, INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR IN THE BRAIN [J].
SCHOBITZ, B ;
DEKLOET, ER ;
HOLSBOER, F .
PROGRESS IN NEUROBIOLOGY, 1994, 44 (04) :397-432
[43]   CELLULAR-LOCALIZATION OF INTERLEUKIN-6 MESSENGER-RNA AND INTERLEUKIN-6 RECEPTOR MESSENGER-RNA IN RAT-BRAIN [J].
SCHOBITZ, B ;
DEKLOET, ER ;
SUTANTO, W ;
HOLSBOER, F .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1993, 5 (11) :1426-1435
[44]  
Shelton RC, 2011, MOL PSYCHIAT
[45]   TNFα signaling in depression and anxiety:: Behavioral consequences of individual receptor targeting [J].
Simen, BB ;
Duman, CH ;
Simen, AA ;
Duman, RS .
BIOLOGICAL PSYCHIATRY, 2006, 59 (09) :775-785
[46]   Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide [J].
Steiner, Johann ;
Bielau, Hendrik ;
Brisch, Ralf ;
Danos, Peter ;
Ullrich, Oliver ;
Mawrin, Christian ;
Bernstein, Hans-Gert ;
Bogerts, Bernhard .
JOURNAL OF PSYCHIATRIC RESEARCH, 2008, 42 (02) :151-157
[47]   Elevated cytokine expression in the orbitofrontal cortex of victims of suicide [J].
Tonelli, L. H. ;
Stiller, J. ;
Rujescu, D. ;
Giegling, I. ;
Schneider, B. ;
Maurer, K. ;
Schnabel, A. ;
Moeller, H. -J. ;
Chen, H. H. ;
Postolache, T. T. .
ACTA PSYCHIATRICA SCANDINAVICA, 2008, 117 (03) :198-206
[48]   Cytokines and serotonin transporter in patients with major depression [J].
Tsao, Chiung-Wen ;
Lin, Yee-Shin ;
Chen, Chwen-Cheng ;
Bai, Chyi-Huey ;
Wu, Shin-Rung .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (05) :899-905
[49]   Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder [J].
Tuglu, C ;
Kara, SH ;
Caliyurt, O ;
Vardar, E ;
Abay, E .
PSYCHOPHARMACOLOGY, 2003, 170 (04) :429-433
[50]   Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial [J].
Tyring, S ;
Gottlieb, A ;
Papp, K ;
Gordon, K ;
Leonardi, C ;
Wang, A ;
Lalla, D ;
Woolley, M ;
Jahreis, A ;
Zitnik, R ;
Cella, D ;
Krishnan, R .
LANCET, 2006, 367 (9504) :29-35